You are here
Home 🌿 Cannabis Technology News 🌿 3 Cannabis Developments to Know: GW Pharma, Canopy Growth, Aurora Cannabis 🌿3 Cannabis Developments to Know: GW Pharma, Canopy Growth, Aurora Cannabis
Warning message
The subscription service is currently unavailable. Please try again later.The cannabis sector is in the early innings of a multi-decade growth cycle that should create more millionaires than the tech boom.
Today, want to provide an update on some of the corporate initiatives at some of the leading global cannabis companies.
Leading Biotech Company Announces New CFO
GW Pharmaceuticals plc (GWPH) announced the appointment of Scott Giacobello as Chief Financial Officer. Giacobello will be based out of Carlsbad, California. The previous CFO (since 2012), Adam George is the Managing Director – UK, a newly-created executive role with broad leadership responsibilities for UK operations.
Giacobello served as Chief Financial Officer for Chase Pharmaceuticals Corporation until Allergan acquired it. Chase was a clinical stage biopharmaceutical company focused on the development and commercialization of improved treatments for neurodegenerative disorders. From 2008 through 2015, Giacobello held senior level finance positions at Allergan, most recently serving as Vice President of Finance for Global Research & Development.
Under his new position, George will make sure the company’s UK operations achieve its goals, which include pipeline development, manufacturing scale-up, and European commercialization. He will continue as GW’s Secretary and will provide Giacobello with full support through the CFO transition.
We are favorable on this announcement and see significant long-term upside to current levels. GWPH is one of the best long-term cannabis investment opportunities and if the market continues to see weakness, a great buying opportunity will be created for potential GWPH investors.
Leading Canadian Cannabis Retailer Faces Legal Headwinds
Canopy Growth Corp (WEED.TO) (TWMJF) is facing legal headwinds after a law firm issued a lawsuit on behalf of a patient of Mettrum. The claim is for millions of dollars and states that Mettrum has failed to pay refunds to its customers for all the marijuana products in question.
Although these issues are mostly priced into shares of Canopy, we would not be surprised if WEED.TO and TWMJF traded lower off this news. The company has seen weakness over the last week and WEED.TO is down 5% during that time.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.